Liverex I NDC 44911-0419

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0419Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0419Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0419-1	44911041901	30 mL in 1 BOTTLE, DROPPER (44911-0419-1)Marketed from Feb 28, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Liverex I
Generic name (nonproprietary): ginkgo biloba, fel tauri, gallbladder (suis), hepar suis), thyroidinum (suis), germanium sesquioxide, alpha-ketoglutaricum acidum, citricum acidum, fumaricum acidum, malicum acidum, manganum metallicum, pyruvic acid, succinicum acidum, naphthochinonum, arsenicum metallicum, sulphur, aconiticum acidum, cis, lycopodium clavatum, natrum oxalaceticum, phosphorus
Active ingredients: Ginkgo — 6 [hp_X]/mLBos taurus bile — 6 [hp_X]/mLSus scrofa gallbladder — 6 [hp_X]/mLPork liver — 6 [hp_X]/mLThyroid — 6 [hp_X]/mLGermanium sesquioxide — 8 [hp_X]/mLOxogluric acid — 8 [hp_X]/mLAnhydrous citric acid — 8 [hp_X]/mLFumaric acid — 8 [hp_X]/mLMalic acid — 8 [hp_X]/mLManganese — 8 [hp_X]/mLPyruvic acid — 8 [hp_X]/mLSuccinic acid — 8 [hp_X]/mL1,4-naphthoquinone — 9 [hp_X]/mLArsenic — 12 [hp_X]/mLSulfur — 12 [hp_X]/mLAconitic acid, (Z)- — 12 [hp_X]/mLLycopodium clavatum spore — 12 [hp_X]/mLSodium diethyl oxalacetate — 12 [hp_X]/mLPhosphorus — 12 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 28, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 44911-0419_eeacc3c5-b06d-467d-b422-1c9f101149a9SPL ID eeacc3c5-b06d-467d-b422-1c9f101149a9SPL set ID 1c23c489-0a43-4736-a30a-0ae02c09fb45UNII 19FUJ2C58T, ET3651ZLOU, B6A98VOI9I, 6EC706HI7F, 6RV024OAUQ, 96WE91N25T, 8ID597Z82X, XF417D3PSL, 88XHZ13131, 817L1N4CKP, 42Z2K6ZL8P, 8558G7RUTR, AB6MNQ6J6L, RBF5ZU7R7K, N712M78A8G, 70FD1KFU70, OF5471ZHRR, C88X29Y479, 6CA025Y4FG, 27YLU75U4WUPC 0363113700589
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911041901 followed by a unit qualifier and the quantity

Package 44911-0419-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 21, 2023.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve abdominal pain and nausea.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)